Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,431
archived clinical trials in
Anemia

A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Augusta, GA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Macon, GA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Macon, GA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Marietta, GA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Evanston, IL
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Evanston, IL
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Evergreen Park, IL
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Evergreen Park, IL
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Kansas, KA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Kansas, KA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Wichita, KA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Baton Rouge, LA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Lafayette, LA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Lafayette, LA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Boston, MA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Springfield, MA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Springfield, MA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Detroit, MI
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Pontiac, MI
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Pontiac, MI
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
St. Louis, MO
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Eatontown, NJ
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Eatontown, NJ
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
New Brunswick, NJ
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
West Orange, NJ
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
West Orange, NJ
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Flushing, NY
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Flushing, NY
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Orchard Park, NY
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Orchard Park, NY
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Syracuse, NY
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Syracuse, NY
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Williamsville, NY
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Williamsville, NY
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Raleigh, NC
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Dayton, OH
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Toledo, OH
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Tulsa, OK
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
mi
from
Lewistown, PA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
mi
from
Lewistown, PA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Philadelphia, PA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Orangeburg, SC
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Orangeburg, SC
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Sumter, SC
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Sumter, SC
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Chattanooga, TN
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Dyersburg, TN
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Dyersburg, TN
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Arlington, TX
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Austin, TX
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Corpus Christi, TX
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Dallas, TX
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Houston, TX
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
San Antonio, TX
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Temple, TX
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Temple, TX
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Tyler, TX
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Tyler, TX
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Alexandria, VA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Alexandria, VA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Fairfax, VA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Fairfax, VA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Richmond, VA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Seattle, WA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Bluefield, WV
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Bluefield, WV
Click here to add this to my saved trials
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
A Randomized Phase III Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated With Radiotherapy for Carcinoma of the Head and Neck
Status: Enrolling
Updated:  11/14/2015
University of Alabama at Birmingham, Comprehensive Cancer Center
mi
from
Birmingham, AL
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
A Randomized Phase III Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated With Radiotherapy for Carcinoma of the Head and Neck
Status: Enrolling
Updated: 11/14/2015
University of Alabama at Birmingham, Comprehensive Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
A Randomized Phase III Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated With Radiotherapy for Carcinoma of the Head and Neck
Status: Enrolling
Updated:  11/14/2015
Comprehensive Cancer Institute of Huntsville
mi
from
Huntsville, AL
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
A Randomized Phase III Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated With Radiotherapy for Carcinoma of the Head and Neck
Status: Enrolling
Updated: 11/14/2015
Comprehensive Cancer Institute of Huntsville
mi
from
Huntsville, AL
Click here to add this to my saved trials
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
A Randomized Phase III Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated With Radiotherapy for Carcinoma of the Head and Neck
Status: Enrolling
Updated:  11/14/2015
Huntsville Hospital System
mi
from
Huntsville, AL
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
A Randomized Phase III Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated With Radiotherapy for Carcinoma of the Head and Neck
Status: Enrolling
Updated: 11/14/2015
Huntsville Hospital System
mi
from
Huntsville, AL
Click here to add this to my saved trials
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
A Randomized Phase III Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated With Radiotherapy for Carcinoma of the Head and Neck
Status: Enrolling
Updated:  11/14/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
A Randomized Phase III Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated With Radiotherapy for Carcinoma of the Head and Neck
Status: Enrolling
Updated: 11/14/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Click here to add this to my saved trials
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
A Randomized Phase III Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated With Radiotherapy for Carcinoma of the Head and Neck
Status: Enrolling
Updated:  11/14/2015
Alabama Oncology, LLC
mi
from
Montgomery, AL
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
A Randomized Phase III Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated With Radiotherapy for Carcinoma of the Head and Neck
Status: Enrolling
Updated: 11/14/2015
Alabama Oncology, LLC
mi
from
Montgomery, AL
Click here to add this to my saved trials